Glenn Reicin

Glenn Reicin

No open positions remaining
61 year
Finance
Health Technology
Consumer Services

Profile

Glenn M.
Reicin
served as Managing Director at Morgan Stanley & Co. LLC from 1993 to 2008.
Director roles were held at Novasys Medical, Inc. (2009-2013), SpinalMotion, Inc. (2009-2014), and SI-BONE, Inc. (2010-2012).
Managing Director at Skyline Management LLC from 2009 to 2012.
Chief Financial Officer & Treasurer at Sigilon Therapeutics, Inc. from 2019 to 2021.
President of Greyrock Biomedical Advisors Ltd. from 2013 to 2019.
Titles also include Independent Director at Amplitude Healthcare Acquisition Corp., Analyst at Fidelity Management & Research Co. LLC, Senior Vice President at Oppenheimer & Co., Inc., Management Consultant at Bain & Co., Inc., Chief Financial & Operating Officer at Alladapt Immunotherapeutics, Inc., and Chief Financial Officer at Harmony Biosciences Holdings, Inc. in 2026.
Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.

Former positions of Glenn Reicin

CompaniesPositionEnd
HARMONY BIOSCIENCES HOLDINGS, INC. Director of Finance/CFO 15/07/2026
SIGILON THERAPEUTICS, INC. Director of Finance/CFO 13/06/2021
President 30/04/2019
Director/Board Member 31/12/2013
Director/Board Member 31/12/2012
See the detail of Glenn Reicin's experience

Training of Glenn Reicin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Finance

Finance

Health Services

Health Technology

Health Technology

Finance

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Finance

Health Technology